The activation of AR by its natural ligand DHT in endocrine-sensitive ER+ cell lines in vitro inhibited proliferation and ER signalling [119,128], consistent with aforementioned clinical studies, supporting the premise that androgens inhibit proliferation and induce tumour regression. This evidence concerns the gene AR and neoplasm.